• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D filed by Akanda Corp.

    2/20/24 5:17:13 PM ET
    $AKAN
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $AKAN alert in real time by email
    SC 13D 1 sc13d.htm SCHEDULE 13D
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13D
    Under the Securities Exchange Act of 1934
    AKANDA CORP.
    (Name of Issuer)

     
    Common Shares, no par value
    (Title of Class of Securities)

    00971M205
    (CUSIP Number)

    Katie Field, Chairman & CEO
    Halo Collective Inc.
    65 Queen Street W., Suite 815
    Toronto, Ontario M5H 2M5 Canada

    Copy to:

    Richard Raymer
    Dorsey & Whitney LLP
    161 Bay Street, Suite 4310
    Toronto, Ontario M5J 2S1 Canada
    (416) 367-7370
    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

    July 25, 2023
    (Date of Event which Requires Filing of this Statement)

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


    CUSIP No. 00971M205
    1
    NAME OF REPORTING PERSONS
    Halo Collective Inc. (the “Reporting Person”)
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) ☐
    (b) ☐
    3
    SEC USE ONLY
    4
    SOURCE OF FUNDS (SEE INSTRUCTIONS)
     
    5
    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2 ☐
    Not Applicable
    6
    CITIZENSHIP OR PLACE OF ORGANIZATION
    Ontario, Canada
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON
    WITH:
    7
    SOLE VOTING POWER
    582,193
    8
    SHARED VOTING POWER
    0
    9
    SOLE DISPOSITIVE POWER
    582,193
    10
    SHARED DISPOSITIVE POWER
    0
    11
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    582,193
    12
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ☐
    NOT APPLICABLE
    13
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    13.0%(1)
    14
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
    CO

    (1)   The percentages used herein are calculated based upon 3,884,786 outstanding shares of the Issuer as of March 9, 2023 plus 582,193 common shares in aggregate underlying convertible securities which are beneficially owned by the Reporting Person and included pursuant to Rule 13d-3(d)(1)(i) of the Act.


    Item 1.
    Security and Issuer
    (a)
    Title of Class of Securities:
    Common Shares, no par value (the “Common Stock”)
    (b)
    Name of Issuer:
    Akanda Corp. (the “Issuer”)
    (c)
    Address of Issuer’s Principal Executive Offices:
    1a, 1b Learoyd Road
    New Romney, TN28 8XU, United Kingdom
    Item 2.
    Identity and Background
    (a)
    Name of Reporting Person:  Halo Collective Inc.
    (b)
    Principal Business Address:  65 Queen Street West, Suite 815, Toronto, Ontario M5H 2M5 Canada
    (c)
    Occupation, Employment and Other Information:  Cannabis cultivation, extraction, manufacturing and distribution;
    (d)
    Criminal Convictions:  Neither the Reporting Person nor its officers or directors have, in the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors);
    (e)
    Civil Proceedings:  Neither the Reporting Person nor its officers or directors have, in the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding been subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws;
    (f)
    Citizenship:  Ontario, Canada.
    Item 3.
    Source and Amount of Funds or Other Consideration:
    OO - See Item 4
    Item 4.
    Purpose of Transaction
    On January 26, 2023, the Issuer issued a promissory note to the Reporting Person in the principal amount of Three Hundred Twenty-Eight Thousand Hundred Dollars ($328,000.00) (the “Note”). The Note bears an interest rate of 7% per annum and has a maturity date on June 25, 2023. If the amount payable is due, whether at stated maturity, by acceleration or otherwise, the overdue amount shall bear and accrue an interest rate of 1.25%.
     
    On July 25, 2023, the Issuer and the Reporting Person entered into a Note Conversion Agreement to convert $360,960 of the total remaining outstanding balance, including accrued interest, under the Note into Common Shares of the Company at $0.62 per share (the “Conversion Shares”). The Issuer and the Reporting Person agreed that after the issuance of the Conversion Shares, the principal balance outstanding under the Note is $0. Upon satisfaction of complying with Nasdaq Capital Market rules, the Issuer issued 582,193 Common Shares to the Reporting Person on August 25, 2023, in full satisfaction of the Note.

    Katie Field, the Chair and Chief Executive Officer of the Reporting Person, has served as a director of the Issuer since February of 2020, and is also acting as the Interim Chief Executive Officer of the Issuer from February 7, 2023, through the date of this report.


    Item 5.
    Interest in Securities of the Issuer
    As of July 25, 2023, the Reporting Person holds the following shares of Common Stock:
    (i) Sole power to vote or to direct the vote:  582,193
    (ii) Shared power to vote or to direct the vote: 0
    (iii) Sole power to dispose or direct the disposition:  582,193
    (iv) Shared power to dispose or direct the disposition: 0
    (v) Aggregate amount of shares beneficially owned:  582,193
    (vi) Percent of class represented in Item (v) above:  13.0%
    The percentage represented in Item 5(vi) above was calculated based upon 3,884,786 outstanding shares of the Issuer as of March 9, 2023 plus 582,193 common shares in aggregate underlying convertible securities which are beneficially owned by the Reporting Person and included pursuant to Rule 13d-3(d)(1)(i) of the Act.

    Item 6.
    Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer
    January 26, 2023 Promissory Note
    July 25, 2023 Note Conversion Agreement
    Item 7.
    Material to Be Filed as Exhibits

    January 26, 2023 Promissory Note - Exhibit 4.3 to the Issuer's F-3 Registration Statement filed with the Securities and Exchange Commission on January 18, 2024
    July 25, 2023 Note Conversion Agreement

    SIGNATURE
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
    Dated: February 16, 2024
    HALO COLLECTIVE INC.

    By:  /s/ Katie Field 
    Katie Field, Chairman & CEO


    Exhibit 7.1  NOTE CONVERSION AGREEMENT

    Note Conversion Agreement
    July 25, 2023

    This Note Conversion Agreement (the “Agreement”) is made as of July 25, 2023 between Halo Collective Inc., an Ontario corporation (the “Holder”), and Akanda Corp., an Ontario corporation (the “Debtor”), in connection with a promissory note with a principal amount of US$328,000 dated January 26, 2023 issued by the Debtor to the Holder (the “Note”).

    1.
    Issuance of Common Shares. Holder and Debtor have agreed to convert
    $360,960 of the amount owing under the Note into Common Shares of the Debtor at $0.62 per share (the “Conversion Shares”), and as such the Debtor hereby issues the Conversion Shares to the Holder. After the issuance of the Conversion Shares, the principal balance outstanding under the Note is $0.

    2.
    Representations of Holder. The Holder makes the following representations:

    (a)
    No portion of the Note has been assigned, pledged or transferred and the Holder owns the Note free and clear of any liens or encumbrances;

    (b)
    Holder is acquiring the Conversion Shares for its own account, it is acquiring such Conversion Shares not for the benefit of any other person, and not with a view to the resale or distribution of the Conversion Shares;

    (c)
    Holder is not acting for the account or benefit of a U.S. person or a person within the United States, and the offer and sale of the Conversion Shares to the Holder has been effected in reliance on Rule 903 of Regulation S of the U.S. Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder (the “Securities Act”);

    (d)
    Holder has knowledge in financial and business affairs, is capable of evaluating the merits and risks of an investment in the Conversion Shares and Holder has not received an offering memorandum or similar disclosure documents;

    (e)
    Holder has been given an adequate opportunity to ask questions of, and receive answers from, the officers of the Debtor concerning the sale of the Conversion Shares and to obtain such additional information as the Holder deems necessary in order to evaluate an investment in the Debtor and the Debtor has provided all information requested by the Holder;

    (f) none of the Conversion Shares have been registered under the Securities Act or under any state securities or “blue sky” laws of any state of the United States, and, unless so registered, may not be offered or sold in the United States or to U.S. Persons, as that term is defined in Regulation S of the Securities Act, except pursuant to an exemption from,
    t subject to, the registration requirements of the Securities Act; and

    - 2 -
    (g) Holder has duly executed and delivered this Agreement to the Debtor and it constitutes a valid and binding agreement of the Holder enforceable against the Holder in accordance with its terms.
    3.
    Notices. All notices, requests, demands and other communications hereunder shall be subject to the provisions under the Note.

    4.
    GOVERNING LAW. THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE PROVINCE OF ONTARIO WITHOUT REGARD TO THE PRINCIPLES OF CONFLICT OF LAW THEREOF.

    5. Counterparts. This Agreement may be executed in two (2) or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Counterparts may be delivered via electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be
    duly and validly delivered and be valid and effective for all purposes.

    IN WITNESS WHEREOF, the Debtor and Holder duly executed and delivered this Agreement as of the date first written above.


    Akanda Corp.


    By:  /s/ Katie Field
     Name:  Katie Field
    Title:  Executive Director

    Halo Collective Inc.



    By:  /s/ Avtar Dhaliwal
    Name:  Avtar Dhaliwal
    Title:  Director

    Get the next $AKAN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AKAN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $AKAN
    SEC Filings

    See more
    • SEC Form 6-K filed by Akanda Corp.

      6-K - AKANDA CORP. (0001888014) (Filer)

      5/1/25 5:00:02 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 20-F filed by Akanda Corp.

      20-F - AKANDA CORP. (0001888014) (Filer)

      4/30/25 3:00:22 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 6-K filed by Akanda Corp.

      6-K - AKANDA CORP. (0001888014) (Filer)

      4/18/25 1:46:03 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care

    $AKAN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by Akanda Corp. (Amendment)

      SC 13D/A - AKANDA CORP. (0001888014) (Subject)

      2/20/24 6:01:03 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13D filed by Akanda Corp.

      SC 13D - AKANDA CORP. (0001888014) (Subject)

      2/20/24 5:17:13 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by Akanda Corp. (Amendment)

      SC 13G/A - AKANDA CORP. (0001888014) (Subject)

      2/20/24 12:55:32 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care

    $AKAN
    Leadership Updates

    Live Leadership Updates

    See more
    • Halo Collective Announces Change of Auditors and Failure to File Cease Trade Order

      Toronto, Ontario--(Newsfile Corp. - June 22, 2023) - Halo Collective Inc. (NEO: HALO) (OTCQB:HCANF) (FSE: A9K0) ("Halo" or the "Company") announces today that it has changed its auditor (the "Change of Auditor") from Macias Gini & O'Connell LLP (the "Former Auditor") to GreenGrowth CPAs (the "Successor Auditor"). The Former Auditor resigned effective June 19, 2023, and the Company's board of directors, upon the audit committee's recommendation, appointed the Successor Auditor to fill the resulting vacancy until the close of the next annual meeting of the Company's shareholders.There was no modified opinion, or other opinion, issued by the Former Auditor in connection with its audit of the Co

      6/22/23 1:06:00 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care
    • Canmart Ends CEO Service Agreement; Akanda Approves Appointment of Director

      International medical cannabis platform company Akanda Corp. ("Akanda" or the "Company") (NASDAQ:AKAN) today announced its subsidiary Canmart Ltd. brought Tejinder Virk's Service Agreement dated June 2, 2021 (the "Service Agreement") to an immediate end with effect from February 13th, 2023. As disclosed on February 7th, 2023, the Company disclosed Mr. Virk's attempt to end the Service Agreement without providing the requisite period of notice required under the Service Agreement, his interpretation of the Service Agreement, and allegations of Breach of Contract. On February 13th, 2023, the Company informed Mr. Virk that it had reached the conclusion that it has a right to bring the Service

      2/16/23 5:05:00 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care
    • /R E P E A T -- Halo Collective Appoints Katie Field as Chairman of the Board/

      TORONTO, Aug. 12, 2022 /PRNewswire/ -  Halo Collective Inc. ("Halo" or the "Company") (NEO: HALO) (OTCQX:HCANF) (Germany: A9KN) today announced the appointment of Katie Field, Chief Executive Officer of Halo, to Chairman of the board of directors of the Company (the "Board"), effective immediately. Current Chairman Ryan Kunkel has resigned from the Board to focus on other professional endeavors. To the knowledge of the Company, Ms. Field is the second woman to serve as Chairman and CEO of a publicly traded cannabis company, the first being Kim Rivers of Trulieve (CSE:TRUL). Ca

      8/12/22 8:00:00 AM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care

    $AKAN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Univest Securities, LLC Announces Closing of $5 Million Underwritten Public Offering for its Client Akanda Corp. (NASDAQ: AKAN)

      New York, March 27, 2024 (GLOBE NEWSWIRE) -- Univest Securities, LLC ("Univest"), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of underwritten public offering (the "Offering") of 3,087,443 common stock priced at $0.1217 per share, with pre-funded warrants exercisable for 37,997,190 shares with respect to the underwritten public offering for its client Akanda Corp. (NASDAQ:AKAN) ("Akanda" or the "Company"), an international medical cannabis company. Under the terms of the securities purchase agreement, the Company has agreed to sell to the institutional investors a total of 3,087,443 sh

      3/27/24 4:45:00 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care
    • Akanda Corp. Announces Signing of Option to Develop Canadian THC and CBD Farming Facility

      International medical cannabis company Akanda Corp. ("Akanda" or the "Company") (NASDAQ:AKAN, WKN: A3DG83))) announces that Akanda (the "Optionee" the "Company") and 1107385 B.C. LTD (the "Owner") have agreed upon terms to purchase farming land and related operations and licenses. The key deal terms are as follows: Akanda will issue a non-refundable payment equal to One Million Eight Hundred Thousand United States Dollars (USD1,800,000) and if paid in common shares of Akanda will be based on formula to calculate the per share price as set forth in the agreement. The initial payment will be broken up into the First Option Payment, the Second Option Payment and the Third Option Payment, u

      9/20/23 9:00:00 AM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care
    • Akanda Corp. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

      International medical cannabis platform company Akanda Corp. ("Akanda" or the "Company") (NASDAQ:AKAN) today announced that the Company has received a written notification (the "Notification Letter") on July 3, 2023 from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that it is not in compliance with the minimum bid price requirement set forth under Nasdaq Listing Rule 5550(a)(2). It resulted from the fact that the closing bid price of the Company's common shares, no par value ("Common Shares"), was below $1.00 per share for a period of 30 consecutive business days. The Notification Letter does not impact the Company's listing on the

      7/6/23 4:18:00 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care

    $AKAN
    Financials

    Live finance-specific insights

    See more
    • Halo Collective Completes Acquisition of Premium Indoor Grow and Distribution Hub in Portland, Oregon

      TORONTO, Sept. 22, 2022 /PRNewswire/ - Halo Collective Inc. ("Halo" or the "Company") (NEO: HALO) (OTCQX:HCANF) (Germany: A9KN) today announced, further to its press release dated August 27, 2021, that it has completed the acquisition of all of the substantial assets of three operating entities doing business as Pistil Point in Oregon which collectively hold multiple cannabis licenses. With this transaction, Halo now has full ownership of a range of indoor and outdoor cultivation, manufacturing, and distributions assets, along with an expanded library of genetics that is expected to allow the Company to continue to execute its vertically integrated strategy in Oregon with enhanced compet

      9/22/22 5:00:00 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care
    • Halo Collective Announces Westwood Dispensary Completion, Local Inspections Passed, and Planned Opening for Second Budega™ in California

      TORONTO, April 12, 2022 /PRNewswire/ - Halo Collective Inc. ("Halo" or the "Company") (NEO: HALO) (OTCQX:HCANF) (Germany: A9KN) today announced that its Budega Westwood Dispensary passed its Los Angeles inspection and is expected to open within 30 days. The Budega Westwood location is perfectly located nestled in between Westwood to the west and Beverly Hills to the east, right off of one of LA's most traveled and famous thoroughfares for locals and visitors, the Santa Monica Boulevard (10461 Santa Monica Blvd) and within two miles of the University of Los Angeles California campus. The facility is leased and near complete with renovations of its approximately 1,500 square foot prime retail

      4/12/22 4:40:00 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care